Show simple item record

dc.contributor.authorBennett, Antonette
dc.contributor.authorPatel, Saajan
dc.contributor.authorMietzsch, Mario
dc.contributor.authorJose, Ariana
dc.contributor.authorLins-Austin, Bridget
dc.contributor.authorYu, Jennifer C.
dc.contributor.authorBothner, Brian
dc.contributor.authorMcKenna, Robert
dc.contributor.authorAgbandje-McKenna, Mavis
dc.identifier.citationBennett, Antonette, Saajan Patel, Mario Mietzsch, Ariana Jose, Bridget Lins-Austin, Jennifer C. Yu, Brian Bothner, Robert McKenna, and Mavis Agbandje-McKenna. "Thermal stability as a determinant of AAV serotype identity." Molecular Therapy - Methods & Clinical Development 6, no. 15 (September 2017): 171-182. DOI:
dc.description.abstractCurrently, there are over 150 ongoing clinical trials utilizing adeno-associated viruses (AAVs) to target various genetic diseases, including hemophilia (AAV2 and AAV8), congenital heart failure (AAV1 and AAV6), cystic fibrosis (AAV2), rheumatoid arthritis (AAV2), and Batten disease (AAVrh.10). Prior to patient administration, AAV vectors must have their serotype, concentration, purity, and stability confirmed. Here, we report the application of differential scanning fluorimetry (DSF) as a good manufacturing practice (GMP) capable of determining the melting temperature (Tm) for AAV serotype identification. This is a simple, rapid, cost effective, and robust method utilizing small amounts of purified AAV capsids (∼25 μL of ∼1011 particles). AAV1-9 and AAVrh.10 exhibit specific Tms in buffer formulations commonly used in clinical trials. Notably, AAV2 and AAV3, which are the least stable, have varied Tms, whereas AAV5, the most stable, has a narrow Tm range in the different buffers, respectively. Vector stability was dictated by VP3 only, specifically, the ratio of basic/acidic amino acids, and was independent of VP1 and VP2 content or the genome packaged. Furthermore, stability of recombinant AAVs differing by a single basic or acidic amino acid residue are distinguishable. Hence, AAV DSF profiles can serve as a robust method for serotype identification of clinical vectors.en_US
dc.description.sponsorshipNational Institutes of Healthen_US
dc.titleThermal stability as a determinant of AAV serotype identityen_US
mus.citation.journaltitleMolecular Therapy - Methods & Clinical Developmenten_US
mus.identifier.categoryLife Sciences & Earth Sciencesen_US
mus.relation.collegeCollege of Letters & Scienceen_US
mus.relation.departmentChemistry & Biochemistry.en_US
mus.relation.universityMontana State University - Bozemanen_US
mus.contributor.orcidBothner, Brian|0000-0003-1295-9609en_US

Files in this item


This item appears in the following Collection(s)

Show simple item record

MSU uses DSpace software, copyright © 2002-2017  Duraspace. For library collections that are not accessible, we are committed to providing reasonable accommodations and timely access to users with disabilities. For assistance, please submit an accessibility request for library material.